Former UFC heavyweight champion Frank Mir has been issued a two-year suspension after testing positive for dehydrochloromethyltestosterone (DHCMT).
The USADA, the third-party organization the UFC hired to conduct year-round drug testing on their entire roster, made the announcement Friday.
According to the USADA, “DHCMT is a non-Specified Substance in the class of Anabolic Agents and prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency (WADA) Prohibited List. The finding of a long-term DHCMT metabolite in Mir’s sample, which was identified through a new detection method by the WADA-accredited laboratory in Tokyo, Japan.”
The USADA initially handed Mir a provisional suspension in April after his in-competition drug test showed a potential violation following last March’s knockout loss to Mark Hunt. Mir immediately denied any wrongdoing and claimed he’s never taken any performance-enhancing drugs during his 16-year career.
Interestingly, the new detection method that the USADA is now using also discovered long-term DHCMT metabolites in Mir’s February 5, 2016 out-of-competition test, which originally came up clean.
The two-year suspension is the heftiest the USADA can hand out for first-time offenders. Mir is eligible to return to action April 8, 2018, two years from the day the USADA discovered his flunked test.
Mir, who turns 38 next month, previously suggested that he might call it a career if this verdict didn’t go his way.
Mir has dropped six of his last eight fights, including two straight.